These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18474761)

  • 1. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study.
    Mozaffarian D; Kamineni A; Prineas RJ; Siscovick DS
    Arch Intern Med; 2008 May; 168(9):969-78. PubMed ID: 18474761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
    McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
    J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in the impact of metabolic syndrome components on mortality in older people: A systematic review and meta-analysis.
    Sergi G; Dianin M; Bertocco A; Zanforlini BM; Curreri C; Mazzochin M; Simons LA; Manzato E; Trevisan C
    Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1452-1464. PubMed ID: 32600955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.
    Hoang K; Zhao Y; Gardin JM; Carnethon M; Mukamal K; Yanez D; Wong ND
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):1007-1015. PubMed ID: 26319502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
    Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between metabolic diseases and all-cause and cardiovascular death in an elderly male population during a 15-year follow-up].
    Sun B; Shao Y; Li J; Tian H; Li C
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):913-8. PubMed ID: 24854911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome, its components, and mortality in the elderly.
    Akbaraly TN; Kivimaki M; Ancelin ML; Barberger-Gateau P; Mura T; Tzourio C; Touchon J; Ritchie K; Berr C
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E327-32. PubMed ID: 20810578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study.
    Chee Cheong K; Lim KH; Ghazali SM; Teh CH; Cheah YK; Baharudin A; Lim HL; Abdul Hamid AM; Mustapha FI; Omar MA
    BMJ Open; 2021 Aug; 11(8):e047849. PubMed ID: 34408040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
    PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.
    Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Metabolic Syndrome and its Components With Mortality in the Elderly: A Cohort Study of 73,547 Taiwanese Adults.
    Yen YF; Hu HY; Lin IF; Lai YJ; Su VY; Pan SW; Ting WY; Su WJ
    Medicine (Baltimore); 2015 Jun; 94(23):e956. PubMed ID: 26061328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefits of metabolic syndrome among older men aged 75 years and over in Taiwan.
    Chiang PH; Liu CL; Lin MH; Peng LN; Chen LK; Chen JD; Hou SM
    J Nutr Health Aging; 2012; 16(6):520-4. PubMed ID: 22659989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
    Lakka HM; Laaksonen DE; Lakka TA; Niskanen LK; Kumpusalo E; Tuomilehto J; Salonen JT
    JAMA; 2002 Dec; 288(21):2709-16. PubMed ID: 12460094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Educational Disparities in Risk for Metabolic Syndrome.
    Kim I; Song YM; Ko H; Sung J; Lee K; Shin J; Shin S
    Metab Syndr Relat Disord; 2018 Oct; 16(8):416-424. PubMed ID: 29975597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age- and sex- specific all-cause mortality risk greatest in metabolic syndrome combinations with elevated blood pressure from 7 U.S. cohorts.
    Yu WW; Randhawa AK; Blair SN; Sui X; Kuk JL
    PLoS One; 2019; 14(6):e0218307. PubMed ID: 31194821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical value of metabolic syndrome and its components with respect to sudden cardiac death using different definitions: Two decades of follow-up from the Tehran Lipid and Glucose Study.
    Masrouri S; Moazzeni SS; Cheraghloo N; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Dec; 21(1):269. PubMed ID: 36463175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.